From The First Year: Age-Related Macular Degeneration by Daniel L. Roberts (Da Capo Press; August 29, 2006) Copeability is something everyone needs at some time or another in the course of life, particularly when experiencing loss of eyesight. It is something deep inside that waits until it is needed. When summoned, it rises to the [Read More]
News
Abortion Drug Offers Hope for People with Central Serous Chorioretinopathy
(Updated August 18, 2018) An abortion drug known as ru486 is showing potential as a treatment for central serous chorioretinopathy (CSC), a condition which can lead to loss of central vision. The drug, also called mifepristone, blocks the action of progesterone, a hormone necessary to sustain pregnancy. It is also a potent antiglucocorticoid agent. Glucocorticoids [Read More]
Age-related Macular Degeneration Does Not Cause Blindness
A revealing opinion poll sponsored by MD Support shows that a strong majority of people affected by AMD do not think of themselves as blind, and they do not want the term to be used to describe their visual impairment. The pronouncement is well known: “age-related macular degeneration (AMD) is the leading cause of blindness [Read More]
Summary of Research and Developments in Macular Degeneration: 2005-2006
by Dan Roberts This is a compilation of significant research in the field of macular degeneration during the period May 2005 through May 2006, beginning with new findings as presented at the 2006 meeting of the Association for Research in Vision and Ophthalmology (ARVO). Triple therapy found to be effective for wet AMD Triple therapy [Read More]
Summary of Research and Developments in Macular Degeneration: 2005-2006
by Dan Roberts This is a compilation of significant research in the field of macular degeneration during the period May 2005 through May 2006, beginning with new findings as presented at the 2006 meeting of the Association for Research in Vision and Ophthalmology (ARVO). Triple therapy found to be effective for wet AMD Triple therapy [Read More]